Baxalta
Baxalta
| Type | Subsidiary |
|---|---|
| Key people | Ludwig Hantson (CEO) |
| Industry | Biotechnology |
| Products | Hemophilia treatments, immunology products |
Baxalta Incorporated was a biopharmaceutical company that specialized in developing and marketing therapies for hematology, immunology, and oncology. It was established in 2015 as a spin-off from Baxter International.
History
Baxalta was created when Baxter International decided to spin off its biopharmaceutical division to focus on its medical products business. The spin-off was completed on July 1, 2015, and Baxalta began trading on the New York Stock Exchange under the ticker symbol BXLT.
In January 2016, Shire announced it would acquire Baxalta for $32 billion. The acquisition was completed in June 2016, and Baxalta became a wholly owned subsidiary of Shire.
Products
Baxalta's product portfolio included treatments for hemophilia, immune disorders, and cancer. Some of its notable products were:
- Advate - a recombinant antihemophilic factor for hemophilia A
- Gammagard - an immunoglobulin therapy for primary immunodeficiency
- Oncaspar - a treatment for acute lymphoblastic leukemia
Research and Development
Baxalta invested heavily in research and development to expand its product offerings and improve existing therapies. The company focused on developing treatments for rare and orphan diseases, leveraging its expertise in biotechnology and genetic engineering.
See also
References
External links
- [Official website of Shire](https://www.shire.com)
Baxalta
Baxalta logo
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
